Insight Molecular Diagnostics Inc. IMDX
2.39 USD -0.08 (-3.24%)
At closeNov 11, 2026, 4:00 PM EST
2.39 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
2.36 Day range 2.65
2.35 52-week range 8.51
- YTD
- -68.13%
- 1 year
- -68.26%
News
defenseworld.net Aclaris Therapeutics (NASDAQ:ACRS) vs. Oncocyte (NASDAQ:IMDX) Financial Contrast Aclaris Therapeutics (NASDAQ: ACRS - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two…
globenewswire.com iMDx to Release Third Quarter Results on November 16, 2026 NASHVILLE, Tenn., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will report third quarter 2026 financial results after the…